Cargando…
Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells
Inhibition of protein-protein interactions by small molecules offers tremendous opportunities for basic research and drug development. One of the fundamental challenges of this research field is the broad lack of available lead structures from nature. Here, we demonstrate that modifications of a chr...
Autores principales: | Lis, Christian, Rubner, Stefan, Roatsch, Martin, Berg, Angela, Gilcrest, Tyler, Fu, Darwin, Nguyen, Elizabeth, Schmidt, Anne-Marie, Krautscheid, Harald, Meiler, Jens, Berg, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727211/ https://www.ncbi.nlm.nih.gov/pubmed/29234062 http://dx.doi.org/10.1038/s41598-017-17600-x |
Ejemplares similares
-
Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD
por: Lim, Precious J., et al.
Publicado: (2009) -
Stafia‐1: a STAT5a‐Selective Inhibitor Developed via Docking‐Based Screening of in Silico O‐Phosphorylated Fragments
por: Natarajan, Kalaiselvi, et al.
Publicado: (2019) -
Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b
por: Elumalai, Nagarajan, et al.
Publicado: (2017) -
Synthesis of Chromone-Related Pyrazole Compounds
por: Santos, Clementina M. M., et al.
Publicado: (2017) -
Chromone and Flavonoid Alkaloids: Occurrence and Bioactivity
por: Khadem, Shahriar, et al.
Publicado: (2011)